Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_assertion type Assertion NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_head.
- NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_assertion description "[The ERM subgroup member merlin/schwannomin is inactivated in the tumor-predisposition syndrome neurofibromatosis 2 (NF2), and the prototypic 4.1 subgroup member, Protein 4.1B, has been implicated in the molecular pathogenesis of breast, lung and brain cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_provenance.
- NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_assertion evidence source_evidence_literature NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_provenance.
- NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_assertion SIO_000772 12356905 NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_provenance.
- NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_assertion wasDerivedFrom befree-20140225 NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_provenance.
- NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_assertion wasGeneratedBy ECO_0000203 NP338878.RABeTL1NfnjLjHcyUlBmxjjCOjBGkirBP4aRgzpelFb7s130_provenance.